【正文】 s SK. Effect of iodinated contrast media on thyroid function in adults. Eur ；14（5）：902907.21．Yamaguchi K，Katayama H，Takashima T，et al. Prediction of severe adverse reaction to ionic and nonionic contrast media in Japan： evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology，1991； 178： 363367.22．Widmark JM. Imagingrelated medications： a class overvies. Proc（Bay Univ Med Cent），2007，20： 408417. 23．Singh J，Daftary contrast media and their adverse reactions：J Nucl Med Technol. 2008；36（2）：6974.24．Thomsen HS，Morcos SK. ESUR guidelines on contrast ；31（2）：13114.25．Thomsen HS，Morcos SK. Contrastmediuminduced nephropathy： is there a new consensus? A review of published guidelines. Eur Radiol，2006； 16： 18351840. 26．Toprak O. Conflicting and new risk factors for contrast induced nephropathy （Review）. J Urol，2007，178： 22772283.27．Toprak O，Cirit M，Yesil M，et al. Impact of diabetic and prediabetic state on development of contrastinduced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant，2007，22： 819826.28．Rao QA，Newhouse JH. Risk of nephropathy after intravenous administration of contrast material： a critical literature analysis. Radiology，2006； 239： 392397.29．Toprak O，Cirit M. Risk factors and therapy strategies for contrastinduced nephropathy. Ren Fail，2006； 28： 365381.30．Katzberg RW，Barrett BJ. Risk of iodinated contrast material： induced nephropathy with intravenous administration. Radiology，2007； 243： 622628.31．李彪，齊海海，裕東潔，等. CockroftGault 公式和簡化MDRD公式估算老年人腎功能準(zhǔn)確性的比較研究. 中華老年醫(yī)學(xué)雜志，2007； 26： 97100.32．Lameire N，Adam A，Becher CR，et al. Baseline renal function screening. Am J Cardiol，2006； 98： 21K26K.33．McCullough PA，Adam A，Becker C，et al. Risk prediction of contrastinduced nephropathy. Am J Cardiol. 2006；98（6 suppl 1）：2736.34．Namasivayam S，Kalra MK，Torres WE，et al. Adverse reactions to intravenous iodinated contrast media： a primer for radiologists. Emerg Radiol，2006； 12：210215.35．Solomon R. The role of osmolality in the incidence of contrastinduced nephropathy： a systemtic review of angiographic contrast media in high risk patients. Kidney Int，2005； 68： 22562263.36．Lameire N，Adam A，Becker C，et al. Baseline renal function screening. Am J Cardiol. 2006； 98（6 suppl 1）：2126.37．Ma YC，Li Z， Chen JH，et al. Modified Glomeruar Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease J Am Soc Nephrol. 2006；17：29372944.38．急性ST段抬高心肌梗死PCI的專家共識(shí).39．Weisbord SD，Palevsky PM. Prevention of contrastinduced nephropathy with volume J Am Soc Nephrol. 2008；3： 273280.40．Mueller C，Buerkle G，Buettner HJ ，et al. Prevention of contrast mediaassociated mephropathy： randomized parison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intem Med ，2002 ，162 ：329336.41．Merten GJ ，Burgess WP，Gray LV ，et al Prevention of contrastinducedinduced Nephropathy with sodium bicarbonate： a randomized controlled trial. JAMA，2004； 291： 23282334.42．Solomon RJ，Natarajan MK，Doucet S，et al. Cardiac Angiography in Renally Impaired Patients （CARE） study： a randomized doubleblind trial of contrastinduced nephropathy in patients with chronic kidney disease. Circulation. 2007；115：3189 –96.43．Reed M，Meier P，Tamhane UU，et al. The relative renal safety of iodixanol pared with lowosmolar contrast media： a metaanalysis of randomized controlled trials. J Am Coll Cardiol Intv. 2009；2：645–54.44．Heinrich MC，Haberle L，Muller V，et al. Nephrotoxicity of isoosmolar iodixanol pared with nonionic lowosmolar contrast media： metaanalysis of randomized controlled trials. Radiology. 2009；250：68–86.45．Persson PB，Hansell P，Liss P. Pathophysiology of contrast mediuminduced Int. 2005；68（1）：1422.46．Fleischmann D. Use of high concentration contrast media： principles and rationale—vascular district. Eur J Radiol. 2003；45：S88S93.47．Cademartiri F，Luccichenti G，Marano R，et al. Spiral CTangiography with one，four，and sixteen slice scanners. Technical note. Radiol Med （Torino）. 2003；106：269283.48．Campbell DR，F(xiàn)lemming BK，Mason WF，et al. A parative study of the nephrotoxicity of iohexol，iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J. 1990；41：133137.49．Chanard J，Jolly D，Doco J. Nephrotoxicity of conventional and low osmolality radiocontrast media. J Nephrol. 1991；4：203209.50．Krumlovsky F，Simon N，Santhanam S. Acute renal failure （ARF） secondary to administration of radiographic contrast material （RCM） [abstract]. Kidney Int. 1976；10：501.51．Krumlovsky FA，Simon N，Santhanam S，et al. Acute renal failure. Association with administration of radiographic contrast material. JAMA. 1978；239：125127.52．Cochran ST，Wong WS，Roe DJ. Predicting angiographyinduced acute renal function impairment： clinical risk model. AJR Am J Roentgenol. 1983；141：10271033.53．Guitterez NV，Diaz A，Timmis GC，et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol. 2002； 15：349354.54．中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)，中華心血管病雜志編輯委員會(huì). .經(jīng)皮冠狀動(dòng)脈介入治療指南（2009 ）. 中華心血管病雜志. 2009； 37（1）： 425.55．ECC Committee，Submittees and Task Forces of the American Heart Association. 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 ；112（24 Suppl）： IV1203.30